col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: American Association for Cancer Research
  original article Journal Date Title Authors All Authors
1 [GO] Blood Cancer Discovery 2021―Sep―15 How to provide the needed protection from COVID-19 to patients with hematologic malignancies Antoni Ribas, Madhav V Dhodapkar, Katie M Campbell, Faith E Davies, Steven D. Gore, Ronald Levy, Lee M Greenberger
2 [GO] Blood Cancer Discovery 2021―Sep―13 Disease and therapy-specific impact on humoral immune responses to COVID-19 vaccination in hematologic malignancies David J Chung, Gunjan L. Shah, Sean M. Devlin, Lakshmi V Ramanathan, Sital Doddi, Melissa S Pessin, et al. (+18)
3 [GO] Blood Cancer Discovery 2021―Sep―13 Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T Cell Therapy Roni Tamari, Ioannis Politikos, David A Knorr, Santosha A Vardhana, Jennifer C Young, LeeAnn T Marcello, et al. (+12)
4 [GO] Cancer Discovery 2021―Sep―01 Impaired CD4 T-cell Response to SARS-CoV-2: Rationale for PD-1 Blockade in Patients with Cancer and COVID-19? Bérengère Salomé, Amir Horowitz
5 [GO] Cancer Discovery 2021―Jul―21 Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective Keith T. Flaherty, James H. Doroshow, Susan Galbraith, Antoni Ribas, Paul G. Kluetz, Richard Pazdur, Marc R. Theoret
6 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Jul―16 Characteristics and outcomes of over 300,000 COVID-19 individuals with history of cancer in the United States and Spain Elena Roel, Andrea Pistillo, Martina Recalde, Anthony G Sena, Sergio Fernandez-Bertolin, Maria Aragon, et al. (+47)
7 [GO] Cancer Discovery 2021―Jul―16 Patients with Solid Tumors Seroconvert after SARS-CoV-2 mRNA Vaccine
8 [GO] Cancer Discovery 2021―Jul―07 COVID-19 Vaccines Complicate Breast Screening
9 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Jul―07 Excess mortality in a nationwide cohort of cancer patients during the initial phase of the COVID 19 pandemic in Belgium Geert Silversmit, Freija Verdoodt, Nancy Van Damme, Harlinde De Schutter, Liesbet Van Eycken
10 [GO] Clinical Cancer Research 2021―Jun―09 A Neoadjuvant Chemotherapy Trial for Early Breast Cancer is Impacted by COVID-19: Addressing Vaccination and Cancer Trials Through Education, Equity, and Outcomes David A. Potter, Alexandra Thomas, Hope S. Rugo
11 [GO] Cancer Discovery 2021―Jun―04 COVID-19 Reshapes Cancer Clinical Research
12 [GO] Cancer Discovery 2021―May―19 Preexisting and post-COVID-19 immune responses to SARS-CoV-2 in cancer patients Tatjana Bilich, Malte Roerden, Yacine Maringer, Annika Nelde, Jonas S Heitmann, Marissa L Dubbelaar, et al. (+16)
13 [GO] Cancer Discovery 2021―May―14 Blood Cancers Diminish Response to COVID-19 Vaccine
14 [GO] Cancer Prevention Research 2021―Apr―28 Q&A: Ned Sharpless on COVID-19 and Cancer Prevention
15 [GO] Cancer Discovery 2021―Apr―12 Repurposing of anticancer drugs expands possibilities for antiviral and anti-inflammatory discovery in COVID-19 Mihaela Aldea, Jean-Marie Michot, Francois-Xavier Danlos, Antoni Ribas, Jean-Charles Soria
16 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Apr―02 Voices of Community Organizations: How Cancer Centers Can Support Communities in the Face of COVID-19 JD Austin, E Lee, RC Shelton, G Hillyer, K Schmitt, P Tehranifar
17 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Apr―02 Financial and Employment Impacts of Cancer and COVID-19 Among African American Cancer Survivors TA Hastert, JJ Ruterbusch, AL Best, FWK Harper, H Thompson, JL Beebe-Dimmer, AG Schwartz
18 [GO] Cancer Discovery 2021―Apr―02 Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic Chris Labaki, Solange Peters, Toni K. Choueiri
19 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Apr―02 Impact of COVID-19 Pandemic on Healthcare Delivery, Behavioral Outcomes, and Financial Stress in 1,253 Individuals with Cancer at Huntsman Cancer Institute (HCI) AR Peoples, C Himbert, CA Hathaway, AC Kirchhoff, J Ose, T Lin, et al. (+9)
20 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Apr―02 Improving Survey Response Rates Among Patients at a Cancer Center During a Global Pandemic CA Hathaway, EM Siegel, B Gonzalez, SS Tworoger
21 [GO] Clinical Cancer Research 2021―Mar―01 Vascular normalization to improve treatment of COVID-19: Lessons from treatment of cancer Lance L Munn, Triantafyllos Stylianopoulos, Natalie K Jain, C Corey Hardin, Melin J Khandekar, Rakesh K. Jain
22 [GO] Cancer Discovery 2021―Feb―26 COVID-19 Prolonged in Patients with Cancer
23 [GO] Cancer Prevention Research 2021―Feb―24 COVID-19 disruptions to endoscopic surveillance in Lynch syndrome Danielle B McKenna, Christina M Dudzik, Shria Kumar, Nadim Mahmud, Bryson W Katona
24 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Feb―05 Will COVID-19 Be the Tipping Point for Primary HPV Self-sampling? Anita W.W. Lim
25 [GO] Clinical Cancer Research 2021―Feb―04 How did we get a COVID-19 vaccine in less than one year? E. John Wherry, Elizabeth M. Jaffee, Nicholas Warren, Gypsyamber D'Souza, Antoni Ribas
26 [GO] Cancer Discovery 2021―Feb―02 Correction: Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers
27 [GO] Cancer Immunology Research 2021―Jan―15 At the Crossroads: COVID-19 and Immune Checkpoint Blockade for Cancer Antoni Ribas, Marina Chiara Garassino
28 [GO] Blood Cancer Discovery 2021―Jan―13 Cancer and COVID-19: On the Quest for Effective Vaccines Marwan Kwok, Edward F. Fritsch, Catherine J. Wu
29 [GO] Cancer Discovery 2020―Dec―30 Patients with Cancer Seroconvert Typically After SARS-CoV-2 Infection
30 [GO] Cancer Research 2020―Dec―22 Is COVID-19 - induced platelet activation a cause of concern for cancer patients? Lenard M. Lichtenberger, K. Vinod Vijayan
31 [GO] Cancer Discovery 2020―Dec―22 Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited Antoni Ribas, Rajarshi Sengupta, Trevan Locke, Sayyed Kaleem Zaidi, Katie M Campbell, John M. Carethers, et al. (+4)
32 [GO] Cancer Discovery 2020―Dec―22 As Pandemic Continues, Screening Concerns Grow
33 [GO] Molecular Cancer Research 2020―Dec―16 Relevance of the Bruton Tyrosine Kinase (BTK) as a target for COVID-19 therapy Miran Rada, Zahraa Qusairy, Marta Massip-Salcedo, Salvador Macip
34 [GO] Cancer Discovery 2020―Dec―11 Survival Factors ID'd for Patients with Blood Cancer + COVID-19
35 [GO] Blood Cancer Discovery 2020―Nov―04 Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers Malin Hultcrantz, Joshua Richter, Cara A. Rosenbaum, Dhwani Patel, Eric L. Smith, Neha Korde, et al. (+24)
36 [GO] Blood Cancer Discovery 2020―Nov―02 Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19 Madhav V. Dhodapkar, Kavita M. Dhodapkar, Rafi Ahmed
37 [GO] Clinical Cancer Research 2020―Oct―13 Similarities in Risk for COVID-19 and Cancer Disparities Lisa Newman, Robert A Winn, John M. Carethers
38 [GO] Blood Cancer Discovery 2020―Oct―13 Don't Compromise Myeloma Care Due to COVID-19 Pandemic! Nikhil C. Munshi, Kenneth C. Anderson
39 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―Sep―25 Examining COVID-19 Preventive Behaviors among Cancer Survivors in the United States: an analysis of the COVID-19 Impact Survey Jessica Y Islam, Marlene Camacho-Rivera, Denise C. Vidot
40 [GO] Cancer Prevention Research 2020―Sep―21 COVID-19, Cancer Care and Prevention Raymond N. DuBois
41 [GO] Cancer Discovery 2020―Sep―18 Repurposing Cancer Drugs for COVID-19
42 [GO] Cancer Prevention Research 2020―Sep―17 Disparities in Cancer Prevention in the COVID-19 Era John M. Carethers, Rajarshi Sengupta, Rea Blakey, Antoni Ribas, Gypsyamber D'Souza
43 [GO] Cancer Discovery 2020―Sep―16 Q&A: Solange Peters on COVID-19, Cancer Intersection; Immunotherapy Biomarkers
44 [GO] Cancer Discovery 2020―Sep―01 COVID-19 Challenges Status Quo for Cancer Care
45 [GO] Cancer Discovery 2020―Aug―19 ICI Impact on COVID-19 Severity Modest at Best
46 [GO] Clinical Cancer Research 2020―Aug―18 The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts Alex Broom, Katherine Kenny, Alexander Page, Nicole Cort, Eric Lipp, Aaron C Tan, et al. (+3)
47 [GO] Blood Cancer Discovery 2020―Jul―31 COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers Malin Hultcrantz, Joshua Richter, Cara A Rosenbaum, Dhwani Patel, Eric L Smith, Neha Korde, et al. (+24)
48 [GO] Cancer Discovery 2020―Jul―31 Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients. David J Pinato, Alberto Zambelli, Juan Aguilar-Company, Mark Bower, Christopher CT Sng, Ramon Salazar, et al. (+58)
49 [GO] Cancer Discovery 2020―Jul―22 Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study Donna R Rivera, Solange Peters, Orestis A Panagiotou, Dimpy P Shah, Nicole M. Kuderer, Chih-Yuan Hsu, et al. (+39)
50 [GO] Cancer Discovery 2020―Jul―15 Cancer Research: The lessons to learn from COVID-19 Chris Bailey, James R M Black, Charles Swanton
51 [GO] Clinical Cancer Research 2020―Jul―02 COVID-19 testing in cancer patients: Does one size fit all? Ainhoa Madariaga, Michelle McMullen, Semira Sheikh, Rajat Kumar, Fei-Fei Liu, Camilla Zimmermann, et al. (+3)
52 [GO] Clinical Cancer Research 2020―Jun―15 Immune-Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era Michele Maio, Omid Hamid, James Larkin, Alessia Covre, Maresa Altomonte, Luana Calabrò, et al. (+6)
53 [GO] Cancer Discovery 2020―Jun―08 COVID-19 Delays Cancer Screenings
54 [GO] Clinical Cancer Research 2020―Jun―05 The World of Clinical Trial Development Post-Covid-19: Lessons Learned from a Global Pandemic. Fatima Karzai, Ravi A. Madan, William Dahut
55 [GO] Cancer Discovery 2020―May―29 Registries Offer Insights on COVID-19-Cancer Connection
56 [GO] Cancer Discovery 2020―May―22 The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2 Beril Tutuncuoglu, Merve Cakir, Jyoti Batra, Mehdi Bouhaddou, Manon Eckhardt, David E Gordon, Nevan J Krogan
57 [GO] Cancer Discovery 2020―May―13 The Era of COVID-19 and the Rise of Science Collectivism in Cancer Research Tobias Janowitz, David A. Tuveson
58 [GO] Cancer Discovery 2020―May―12 Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers Jia Luo, Hira Rizvi, Jacklynn V Egger, Isabel R Preeshagul, Jedd D. Wolchok, Matthew D. Hellmann
59 [GO] Cancer Discovery 2020―May―05 Cytokine Storm Drugs Move from CAR T to COVID-19
60 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―May―05 The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action Andrew T. Chan, David A. Drew, Long H. Nguyen, Amit D. Joshi, Wenjie Ma, Chuan-Guo Guo, et al. (+54)
61 [GO] Cancer Discovery 2020―May―01 Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System Vikas Mehta, Sanjay Goel, Rafi Kabarriti, Daniel Cole, Mendel Goldfinger, Ana Acuna-Villaorduna, et al. (+13)
62 [GO] Cancer Discovery 2020―Apr―28 Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak Mengyuan Dai, Dianbo Liu, Miao Liu, Fuxiang Zhou, Guiling Li, Zhen Chen, et al. (+32)
63 [GO] Cancer Discovery 2020―Apr―24 COVID-19 Hits Cancer Research Funding
64 [GO] Cancer Discovery 2020―Apr―20 COVID-19 More Frequent, Severe in Cancer Patients
65 [GO] Clinical Cancer Research 2020―Apr―20 Adapting to a pandemic - conducting oncology trials during the SARS-CoV-2 pandemic Aaron C Tan, David M Ashley, Mustafa Khasraw
66 [GO] Cancer Discovery 2020―Apr―17 Harnessing CAR T Cell Insights to Develop Treatments for Hyperinflammatory Responses in COVID-19 patients Sangya Agarwal, Carl H. June
67 [GO] Cancer Discovery 2020―Apr―15 AACR Calls on Congress to Take Immediate Action Against COVID-19 and Protect Patients with Cancer During the Pandemic
68 [GO] Cancer Discovery 2020―Apr―10 Cancer Care Goes Virtual in Response to COVID-19
69 [GO] Cancer Discovery 2020―Apr―10 TMPRSS2 and COVID-19: Serendipity or opportunity for intervention? Konrad H. Stopsack, Lorelei A. Mucci, Emmanuel S. Antonarakis, Peter S. Nelson, Philip W. Kantoff
70 [GO] Cancer Discovery 2020―Apr―01 Clinical Research Slows as COVID-19 Surges
71 [GO] Cancer Discovery 2020―Mar―31 Cancer Labs Pivot to Battle COVID-19
72 [GO] Cancer Discovery 2020―Mar―24 COVID-19 Challenges Basic Researchers


Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.006 sec